Guanhao Biotech: Net profit of 24.346 million yuan in 2025, down 11.2% year-on-year

People’s Financial News, March 25 — Guanhao Biotech (300238) announced its annual report on March 25. In 2025, the company achieved operating revenue of 388 million yuan, a year-on-year increase of 2.72%; net profit attributable to shareholders was 24.346 million yuan, a decrease of 11.2% year-on-year; basic earnings per share were 0.09 yuan. In 2025, the company’s drug sales volume increased by 59.12% year-on-year, production volume increased by 379.97%, and ending inventory increased by 1433.36%.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin